Viewing Study NCT06392321



Ignite Creation Date: 2024-05-06 @ 8:28 PM
Last Modification Date: 2024-10-26 @ 3:28 PM
Study NCT ID: NCT06392321
Status: COMPLETED
Last Update Posted: 2024-04-30
First Post: 2024-04-26

Brief Title: Dexmedetomidine vs Fentanyl in Controlling Labor Pain
Sponsor: Al-Azhar University
Organization: Al-Azhar University

Study Overview

Official Title: Dexmedetomidine Versus Fentanyl as an Adjuvant to Single Low Dose Spinal Anesthesia in Controlling Labor Pain a Randomized Controlled Study
Status: COMPLETED
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: As most woman experience agonizing pain throughout vaginal labor Adjuvants were added to intrathecal bupivacaine aiming to improve the quality of analgesia This study aimed to assess the efficacy and outcome of intrathecal dexmedetomidine and fentanyl in controlling pain during delivery
Detailed Description: Throughout vaginal deliveries many women suffered from pain providing suitable analgesia is crucial Lupu et al 2023 Spinal anesthesia can provide pain management Parikh et al 2018

Various types of analgesics can be combined to get the needed duration of perioperative analgesia Dexmedetomidine has been used with effective pain management outcomes Shrestha et al 2023 Fentanyl can help pain relief in short duration procedures Show et al 2022

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None